Clinical Trials › NCT05168384
Active, Not RecruitingPhase 1
Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis
Sponsored by Abu Dhabi Stem Cells Center
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 15
Target enrollment
Mar 2022
Start date
Dec 2025
Expected completion
Interventions / Treatments
Extracorporeal PhotopheresisMS standard of care
Conditions studied
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.